Targeted Literature Review to Describe Safety Outcomes in Immune Thrombocytopenia Patients Treated With Thrombopoietin-Receptor Agonists

04/11/2019
23/04/2024
EU PAS number:
EUPAS32139
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

01.02.06 Public Redacted Protocol Ver 1.0 2019-10-15 English

English (362.2 KB - PDF) View document
Study results
Study results

SLR Executive Summary 2020-05-23

English (96.25 KB - PDF) View document
Study report
Other information